AZD0364 is a potent and selective ERK1/2 inhibitor which enhances anti-tumour activity in KRAS mutant tumour models when combined with the MEK inhibitor selumetinib
| Image |  |
|---|---|
| Description | scientific article published on 03 December 2020 |
| Author/s |
author: Elizabeth A Coker Francis D Gibbons Mathew J Garnett Patricia Jaaks Sigourney Bell |
| Publication date | December 3, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |